-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Good news! Shijiazhuang No.4 Pharmaceutical’s peritoneal dialysis solution product has become the first to receive approval for consistency evaluation.
Category:
Time：2022-07-05
Recently, the peritoneal dialysis solution (lactate–G1.5%) (2000 ml, containing 1.5% glucose), developed by Shijiazhuang Fourth Pharmaceutical Co., Ltd., has been approved by the National Medical Products Administration following the evaluation of generic drug quality and therapeutic equivalence. This makes it the first domestic enterprise to receive such approval.
Recently, the peritoneal dialysis solution (lactate–G1.5%) (2000 ml, containing 1.5% glucose), developed by Shijiazhuang No.4 Pharmaceutical Co., Ltd., has been approved by the National Medical Products Administration following a review of generic drug quality and therapeutic equivalence. This makes it the first domestic enterprise to receive such approval.
It is reported that peritoneal dialysis solution (lactate) is primarily used for patients with chronic renal failure who, due to the ineffectiveness of non-dialytic treatments, require continuous ambulatory peritoneal dialysis.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license